Rare, Pediatric Drug Development and Reimbursement Boosted In Shaky US Spending Deal

 
• By Sarah Karlin-Smith
  
Little girl at doctor's appointment.
Rare and pediatric disease drug development and coverage may get a late 2024 boost from Congress. (Shutterstock)

More from Legislation

More from Advanced Technologies